Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ANAREX TABLETS - HSA Drug Approval Details

Approvals/HSA/ANAREX TABLETS

Approved

THERAPEUTIC

ANAREX TABLETS

BEACONS PHARMACEUTICALS PTE LTD🇸🇬 Health Sciences Authority

Approval Date: Mar 30, 1991
Approval ID: a6b9d532febb4642
Company: BEACONS PHARMACEUTICALS PTE LTD
Type: Therapeutic

Approval Details

Approval Id: a6b9d532febb4642
Drug Name: ANAREX TABLETS
Product Name: ANAREX TABLETS
Approval Number: SIN05584P
Approval Date: 1991-03-30
Registrant: BEACONS PHARMACEUTICALS PTE. LTD.
Licence Holder: BEACONS PHARMACEUTICALS PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: M03BC51
Atc Item Name: orphenadrine, combinations
Pharma Manufacturer Name: BEACONS PHARMACEUTICALS PTE. LTD.
Company Detail Path: /organization/beacons-pharmaceuticals-pte-ltd

Active Ingredients

ORPHENADRINE CITRATE

35 mg

PARACETAMOL

450 mg

ORPHENADRINE CITRATE

35 MG

PARACETAMOL

450 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Mar 30, 1991

Approval ID

a6b9d532febb4642

Type

Therapeutic

Back to HSA Approvals